Currently Enrolling Studies

Alzheimer's Disease Center (ADC) Program Registry

This study is funded with a grant from the National Institute of Health (NIH). This study is enrolling adults aged 60 and older without memory problems, or 55 and older with memory problems, to participate in our ADC program registry. Adults will receive a series of three visits, including memory assessments, cognitive testing, lab draws, and physical function testing. These visits will be conducted on an annual basis. All subjects are asked to bring a study partner to the first visit.
• Learn more about the KU ADC Program Registry 

Supervised Exercise Program in Early Alzheimer's Disease (ADEPT)

This six-month study will enroll 80 participants 55 years and older who have early Alzheimer's disease. Participants will attend an exercise facility close to home and perform cardiovascular exercise or do stretching and toning exercises 4 days a week. The participant will have memory assessments, MRI scans, laboratory sampling and fitness testing. This study is examining if aerobic exercise slows the progression of Alzheimer's disease. This study is also funded with a grant from the NIH. 
• Click here to see whether you qualify

MK 8931-017 (EPOCH)

This study is evaluating the safety and efficacy of a study medication for treatment of Alzheimer's Disease.  Participants in this study will take an oral medication once daily for 18 months and come to the clinic for approximately 10 visits throughout the study.   Study procedures include MRI's, ophthalmology exams, ECG's, pen and paper thinking tests, blood draws for lab tests, and questionnaires/interviews.  Participants will be compensated $100 and their study partners will be compensated $50 for each study visit completed.  This study is sponsored by Merck Sharp & Dohme Corp.

• Click here to see whether you qualify

Alzheimer's Prevention Program (APP)

This new study is a comprehensive research effort to examine strategies to improve health and reduce your risk for chronic diseases, including Alzheimer's disease. We are now enrolling participants 65 years and older without Alzheimer's or dementia for the Alzheimer's Prevention Program (APP). One of the goals of the APP is to learn about potential risk factors and what protective behaviors can effectively reduce the risk of developing Alzheimer's disease. The program focuses on how exercise and nutrition influence healthy and unhealthy aging. Study subjects will receive a risk assessment with an amyloid PET scan, general health screen, healthy lifestyle prescription, and surveillance examinations at follow ups.

• Click here to see whether you qualify

Insulin For Memory (INFORM)

This study characterizes the relationship between insulin sensitivity and memory. This study will consist of a one-time, 5-6 hour visit to measure insulin sensitivity using a procedure called a hyperinsulinemic clamp. Insulin in the body will be increased to approximate levels that are experienced following a meal, and short memory tests will be given prior to and during increased insulin. Glucose will be administered along with insulin to maintain normal blood glucose levels. Compensation for participation is $75. To participate in this study, individuals must be part or be willing to enroll in the ADC Registry.
• Click here to see whether you qualify

Measuring Physical Activity in Adults with and without Alzheimer's (MPA)

The purpose of the study is to understand the types and amounts of physical activities older adults do in their everyday life. This is a 1 week study in which participants wear a small electronic monitor that measures the amount of activity they do throughout the day. Participants or study partners will keep a diary of the participant's daily activities. At the end of the study, participants and their caregivers will be compensated up to $100 for their participation.
• Click here to see whether you qualify

ASPirin in Reducing Events in the Elderly (ASPREE)

This study is sponsored through the National Institute on Aging and is enrolling adults aged 65 and older who do not have memory problems. The study seeks to understand how low doses of aspirin may help promote healthy aging and may help to prevent Alzheimer's disease. At this time, the National Institute on Aging is only enrolling individuals who are not Caucasian. Study subjects will complete two screening visits during the first year of the program, and attend annual study visits for a period of five years.
• Click here to see whether you qualify

• A list of previous studies and ongoing studies closed to enrollment may be found here.

Related Research Information Sites:

National Institute on Aging

Alzheimer's Disease Cooperative Study

Alzheimer's Association TrialMatch

Last modified: Dec 17, 2013
How to Join


If you are interested in learning more about joining a KU ADC research study, complete this form.

Questions? Contact us at or call 913-588-0555.